Similar articles

• Value of saliva anticonvulsant monitoring in pregnancy and the newborn.

  Knott C, Reynolds F. Knott C, et al. J Clin Chem Clin Biochem. 1989 Apr;27(4):227-8. J Clin Chem Clin Biochem. 1989. PMID: 2738524 No abstract available.
• [Monitoring therapy by analysis of the drug concentration of saliva].

  Bartels H, Günther E, Wallis S. Bartels H, et al. Monatsschr Kinderheilkd. 1983 Jan;131(1):13-6. Monatsschr Kinderheilkd. 1983. PMID: 6835213 German.
• Monitoring saliva anticonvulsant levels in children.

  Rylance GW. Rylance GW. Dev Med Child Neurol. 1979 Jun;21(3):387-90. doi: 10.1111/j.1469-8749.1979.tb01632.x. Dev Med Child Neurol. 1979. PMID: 467821 No abstract available.
• Therapeutic drug monitoring in saliva.

  Danhof M, Breimer DD. Danhof M, et al. Clin Pharmacokinet. 1978 Jan-Feb;3(1):39-57. doi: 10.2165/00003088-197803010-00003. Clin Pharmacokinet. 1978. PMID: 25155 Review. No abstract available.
• Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants.

  Wilbur R, Kulik FA. Wilbur R, et al. Am J Hosp Pharm. 1981 Aug;38(8):1138-43. Am J Hosp Pharm. 1981. PMID: 6791497 Review.